Strategic Revitalization of an asset-backed, Pharmaceutical Manufacturing Platform with pre-IPO upside in Serbia

Overview This opportunity offers investors access to a pre-IPO public equity investment in a pharmaceutical manufacturing platform being relaunched in Southeast Europe through a listed European holding structure. The project involves integrating an established pharmaceutical company into a publicly traded vehicle, allowing investors to participate in the early growth phase before a potential public market […]

CM3 MULTI-ASSET MONTHLY & BIANNUAL RETURN